Abstract
Rucaparib monotherapy in the heavily pre-treated metastatic castrate-resistant prostate cancer setting: practical considerations and alternate treatment approaches
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have